FLFenfang Li

Fenfang Li

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article

Previous Organizations / Institutes

The organizations / institutes from the scholar's other articles in the past ten years


Fenfang Li has a total of 32 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Dual burden of malnutrition in US Affiliated Pacific jurisdictions in the Children’s Healthy Living Program

    by Rachel Novotny, Fenfang Li, Rachael Leon Guerrero, Patricia Coleman, Aifili J. Tufa, Andrea Bersamin, Jonathan Deenik, Lynne R Wilkens

    Few data are available on dual burden of under and over nutrition of children in the Pacific region. The objective was to examine prevalence of stunting at birth and current stunting and their relationship to obesity in US Affiliated Pacific (USAP) jurisdictions. Cross sectional survey with cluster sampling by community. 5558, 2–8 years olds were measured in 51 communities in 11 USAP jurisdictions. The main outcome measures were stunting at birth, current stunting and obesity by body mass index. Prevalences of stunting at birth, current stunting and obesity were determined, adjusting for age distribution and community clustering. Differences by among age, sex, race and jurisdiction income levels were evaluated by chi-square analysis. Relationships of stunting at birth and current stunting with obesity were examined using a hierarchical model accounting for the study design. Prevalences were stunting at birth 6.8% (Standard Error, SE = 0.9%), current stunting 1.4% (SE = 0.2%) and obesity 14.03.8% (SE = 0.9%). Obesity was highest in upper middle income jurisdictions (UMIJ) at 17.5%. Stunting at birth differed by race (p = 0.0001) with highest prevalence among Native Hawaiian/Pacific Islanders (10.7%). Prevalence of stunting at birth was different by jurisdiction income level with 27.5% in lower middle income jurisdictions (LMIJ), and 22.2% in UMIJ, and 5.5% in higher than high income jurisdictions (HIJ) at 5.5% (p < 0.0001). Prevalence of current stunting was higher in LMIJ than HIJ (p = 0.001), although children with current stunting were less likely to have been stunted at birth. The association between stunting at birth and current stunting was negative (OR = 0.19, 95% CI: 0.05–0.69). Currently stunted children were marginally less likely to be obese than not stunted children in the USAP, where the prevalence of current stunting is low. Stunting (at birth and current) was highest in LMIJ, while UMIJ jurisdictions had the highest dual burden of malnutrition (that is the highest combination of both stunting at birth and obesity). National Institutes for Health clinical trial # NCT01881373 (clinicaltrials.gov).


  • Open Access

    Quality assurance of data collection in the multi-site community randomized trial and prevalence survey of the children’s healthy living program

    by Ashley Yamanaka, Marie Kainoa Fialkowski, Lynne Wilkens, Fenfang Li, Reynolette Ettienne, Travis Fleming, Julianne Power, Jonathan Deenik, Patricia Coleman, Rachael Leon Guerrero, et al.

    Quality assurance plays an important role in research by assuring data integrity, and thus, valid study results. We aim to describe and share the results of the quality assurance process used to guide the data collection process in a multi-site childhood obesity prevalence study and intervention trial across the US Affiliated Pacific Region. Quality assurance assessments following a standardized protocol were conducted by one assessor in every participating site. Results were summarized to examine and align the implementation of protocol procedures across diverse settings. Data collection protocols focused on food and physical activity were adhered to closely; however, protocols for handling completed forms and ensuring data security showed more variability. Quality assurance protocols are common in the clinical literature but are limited in multi-site community-based studies, especially in underserved populations. The reduction in the number of QA problems found in the second as compared to the first data collection periods for the intervention study attest to the value of this assessment. This paper can serve as a reference for similar studies wishing to implement quality assurance protocols of the data collection process to preserve data integrity and enhance the validity of study findings. Trial registration: NIH clinical trial #NCT01881373


  • Anthropometric measurement standardization in the US‐affiliated pacific: Report from the Children's Healthy Living Program

    by Fenfang Li, Lynne R. Wilkens, Rachel Novotny, Marie K. Fialkowski, Yvette C. Paulino, Randall Nelson, Andrea Bersamin, Ursula Martin, Jonathan Deenik, Carol J. Boushey

    Objectives: Anthropometric standardization is essential to obtain reliable and comparable data from different geographical regions. The purpose of this study is to describe anthropometric standardization procedures and findings from the Children's Healthy Living (CHL) Program, a study on childhood obesity in 11 jurisdictions in the US‐Affiliated Pacific Region, including Alaska and Hawai‘i.Methods: Zerfas criteria were used to compare the measurement components (height, waist, and weight) between each trainee and a single expert anthropometrist. In addition, intra‐ and inter‐rater technical error of measurement (TEM), coefficient of reliability, and average bias relative to the expert were computed.Results: From September 2012 to December 2014, 79 trainees participated in at least 1 of 29 standardization sessions. A total of 49 trainees passed either standard or alternate Zerfas criteria and were qualified to assess all three measurements in the field. Standard Zerfas criteria were difficult to achieve: only 2 of 79 trainees passed at their first training session. Intra‐rater TEM estimates for the 49 trainees compared well with the expert anthropometrist. Average biases were within acceptable limits of deviation from the expert. Coefficient of reliability was above 99% for all three anthropometric components.Conclusions: Standardization based on comparison with a single expert ensured the comparability of measurements from the 49 trainees who passed the criteria. The anthropometric standardization process and protocols followed by CHL resulted in 49 standardized field anthropometrists and have helped build capacity in the health workforce in the Pacific Region. Am. J. Hum. Biol. 28:364–371, 2016.


    • 1 May 2010
      • Vol. 69  (5) , 126-9

    Profile of methicillin-resistant Staphylococcus aureus among nursing home residents in Hawai'i.

    by Fenfang Li, Pamela Arnsberger, F DeWolfe Miller

    Residing in long-term care facilities has long been identified as a risk factor for methicillin-resistant Staphylococcus aureus (MRSA) carriage and infection. The objective of this study was to describe MRSA epidemiology among residents in skilled nursing and intermediate care facilities (SNF/ICF) in Hawai'i, using a statewide, population-based antimicrobial resistance surveillance system. From 2000 to 2005, proportions of MRSA increased significantly during the 6-year study period, from 35.0% in 2000 to 58.6% in 2005 (p < 0.001). High levels of MRSA resistance to several commonly used antibiotics were observed, e.g., the level of MRSA resistance to clindamycin, ciprofloxacin, and erythromycin was at 77%, 90%, and 89% respectively. Nevertheless, there is a significant difference in the MRSA resistance pattern against certain antimicrobials in different geographic areas. For example, the level of MRSA resistance to trimethoprim-sulfamethoxazole was close to zero in Hawai'i County, but 13% in Kaua'i County. In contrast, the MRSA resistance to tetracycline was 46% in Hawai'i County, but 5% in Kaua'i County. Multi-drug resistant MRSA was well-established among nursing homes in Hawai'i. Regional antibiograms are important in the assistance of empirical therapy.


    • 1 April 2010
      • Vol. 69  (4) , 99-102

    Epidemiology of methicillin-resistant Staphylococcus aureus among incarcerated population in Hawai'i, 2000-2005.

    by Fenfang Li, F DeWolfe Miller, Paul V Effler

    It is estimated in this study the proportion and incidence of MRSA among the entire state of Hawai'i inmate population over a period of six years, using a statewide, population-based antimicrobial resistance surveillance system. Trend analyses were conducted on both MRSA proportion and MRSA incidence rates including MRSA patterns of antimicrobial resistance to other antibiotics. During the period from 2000 to 2005, 521 (69%) of 753 S. aureus isolates were MRSA. A significant increase in the proportion of MRSA were identified from both jail and prison inmates (p < 0.01). A significant increase in MRSA incidence was also observed among jail inmates (p = 0.005) but not among prison inmates (p = 0.18). A majority of non-beta-lactams, including clindamycin, tetracycline, and trimethoprim-sulfamethoxazole remained as a good choice for the treatment of MRSA infections among inmate population in Hawai'i. Active surveillance of MRSA infection in the inmate population is an important public health tool and should be continued.


  • Open Access

    Isolate Removal Methods and Methicillin-resistantStaphylococcus aureusSurveillance

    by Fenfang Li, Tracy L. Ayers, Sarah Y. Park, F. DeWolfe Miller, Ralph MacFadden, Michele Nakata, Myra Ching Lee, Paul V. Effler

    The effect of duplicate isolate removal strategies on Staphylococcal aureus susceptibility to oxacillin was compared by using antimicrobial test results for 14,595 isolates from statewide surveillance in Hawaii in 2002. No removal was compared to most resistant and most susceptible methods at 365 days and to the National Committee for Clinical Laboratory Standards (NCCLS) and Cerner algorithms at 3-, 10-, 30-, 90-, and 365-day analysis periods. Overall, no removal produced the lowest estimates of susceptibility. Estimates with either NCCLS or Cerner differed by <2% when the analysis period was the same; with either method, the difference observed between a 90- and a 365-day period was <1%. The effect of duplicate isolate removal was greater for inpatient than outpatient settings. Considering the ease of implementation and comparability of results, we recommend using the first isolate of a given species per patient to calculate susceptibility frequencies for S. aureus to oxacillin.


  • Open Access

    Methicillin-resistantStaphylococcus aureus, Hawaii, 2000–2002

    by Fenfang Li, Sarah Y. Park, Tracy L. Ayers, F. DeWolfe Miller, Ralph MacFadden, Michele Nakata, Myra Ching Lee, Paul V. Effler

    The emergence of methicillin-resistant Staphylococcus aureus (MRSA) has generated considerable concern among medical and public health professionals. We used a statewide, population-based antimicrobial resistance surveillance system to examine epidemiologic trends for MRSA from outpatients and inpatients in Hawaii. Pediatric and adult patient populations were compared to assess characteristics of MRSA isolates specific for each group. From 2000 to 2002, 8,206 (26%) of 31,482 total S. aureus isolates were MRSA. During this period, the proportion of MRSA isolates increased in both outpatient and inpatient clinical settings (p<0.01). When stratified by age, annual trends showed a significant increase in the proportion of MRSA in adult patients (from 24% to 30%, p0.05). Although MRSA isolates from adults demonstrated high resistance to most non–β-lactams, most MRSA isolates from pediatric outpatients remained susceptible to most non–β-lactams.